Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
| dc.contributor.author | Colombo, Nicoletta | |
| dc.contributor.author | Dubot, Coraline | |
| dc.contributor.author | Lorusso, Domenica | |
| dc.contributor.author | Caceres, M. Valeria | |
| dc.contributor.author | Hasegawa, Kosei | |
| dc.contributor.author | Shapira-Frommer, Ronnie | |
| dc.contributor.author | Tewari, Krishnansu S. | |
| dc.date.accessioned | 2025-05-10T15:21:54Z | |
| dc.date.issued | 2022 | |
| dc.department | İstanbul Medeniyet Üniversitesi | |
| dc.description.abstract | [No abstract available] | |
| dc.identifier.doi | 10.1097/01.ogx.0000805152.09501.f1 | |
| dc.identifier.endpage | 31 | |
| dc.identifier.issn | 0029-7828 | |
| dc.identifier.issue | 1 | |
| dc.identifier.scopus | 2-s2.0-85123362104 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.startpage | 30 | |
| dc.identifier.uri | https://doi.org/10.1097/01.ogx.0000805152.09501.f1 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14730/6221 | |
| dc.identifier.volume | 77 | |
| dc.indekslendigikaynak | Scopus | |
| dc.language.iso | en | |
| dc.publisher | Lippincott Williams and Wilkins | |
| dc.relation.ispartof | Obstetrical and Gynecological Survey | |
| dc.relation.publicationcategory | Diğer | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_Scopus_20250302 | |
| dc.subject | antineoplastic metal complex; bevacizumab; carboplatin; cisplatin; paclitaxel; pembrolizumab; placebo; programmed death 1 ligand 1; adult; cancer chemotherapy; cancer patient; cancer radiotherapy; cancer recurrence; cancer survival; controlled study; double blind procedure; drug efficacy; drug safety; febrile neutropenia; female; follow up; human; intention to treat analysis; major clinical study; metastasis; multiple cycle treatment; Note; outcome assessment; overall survival; phase 3 clinical trial; progression free survival; protein expression; randomized controlled trial; superiority trial; treatment duration; tumor cell; urinary tract infection; uterine cervix cancer; young adult | |
| dc.title | Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer | |
| dc.type | Note |
Dosyalar
Orijinal paket
1 - 1 / 1










